PSP Pharma
PSP Pharma, also known as PSP Pharmaceuticals, is a prominent player in the pharmaceutical industry, headquartered in Georgia (GE). Founded in 2005, the company has established itself as a leader in the development and distribution of innovative healthcare solutions across the region, with a strong presence in Eastern Europe and Central Asia. Specialising in a diverse range of therapeutic areas, PSP Pharma offers unique products that cater to the evolving needs of healthcare professionals and patients alike. Their commitment to quality and innovation has earned them a reputable market position, marked by significant milestones in research and development. With a focus on enhancing patient outcomes, PSP Pharma continues to expand its portfolio, delivering high-quality pharmaceuticals that stand out for their efficacy and safety. The company’s dedication to excellence has solidified its status as a trusted partner in the healthcare sector.
DitchCarbon Score
How does PSP Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PSP Pharma's score of 11 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
PSP Pharma's reported carbon emissions
In 2023, PSP Pharma reported total carbon emissions of approximately 8,363,480 kg CO2e, a notable decrease from about 10,362,920 kg CO2e in 2022. The emissions breakdown for 2023 includes approximately 5,371,320 kg CO2e from Scope 1 and about 2,992,160 kg CO2e from Scope 2. This trend indicates a commitment to reducing their carbon footprint. Looking ahead to 2024, PSP Pharma's emissions are projected to include approximately 8,829,860 kg CO2e from Scope 1 and about 5,694,420 kg CO2e from Scope 2. While specific reduction targets or initiatives have not been disclosed, the company is actively monitoring and reporting its emissions, reflecting an awareness of its environmental impact. PSP Pharma's ongoing efforts to manage and reduce carbon emissions align with industry standards for climate accountability, although no formal climate pledges or science-based targets have been established at this time. The company continues to focus on transparency in its emissions reporting, which is crucial for stakeholders and the broader community.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 4,587,780 | 0,000,000 | 0,000,000 |
| Scope 2 | 5,775,140 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PSP Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
